期刊文献+

聚乙二醇干扰素治疗慢性丙型肝炎疗效及其影响因素 被引量:7

Treatment of chronic hepatitis C with peginterferon alpha-2a and the factors influencing the effect of this treatment
原文传递
导出
摘要 丙型肝炎病毒(HCV)是引起输血后肝炎和散发性非甲非乙型肝炎的主要病原,其中20%~30%的患者可进展为肝硬化甚至肝癌,对人类危害极大.10多年来,干扰素α曾被选择性地用于治疗慢性丙型肝炎(简称慢丙肝)[1],它对于改善患者肝功能、预防肝纤维化乃至HCV相关的肝癌具有重要意义,然而只有10%~15%的患者能治疗成功.近年,聚乙二醇干扰素(PEG-IFN)已被用于慢性肝病和肝硬化治疗的临床研究,其持久的病毒应答、生物化学和组织学的应答显著高于传统的干扰素[2].研究旨在探讨PEG-IFNα-2a治疗慢丙肝的疗效及其影响因素.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2005年第4期302-304,共3页 Chinese Journal of Hepatology
关键词 聚乙二醇 干扰素 治疗 慢性丙型肝炎 影响因素 Hepacivirus Polyethylene glycols Interferon alfa-2a
  • 相关文献

参考文献8

  • 1中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14006
  • 2Ajello A, Freni MA, Spadaro A, et al. Ten year follow-up of patients with chronic hepatitis C treated with interferon. Hepatogastroenterology, 1999, 46: 2447-2450.
  • 3Reddy KR, Wright TL, Pockros PJ, et al. Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C. Hepatology, 2001, 33: 433-438.
  • 4唐小平,钱可平,许毅玲,袁小珍.慢性丙型肝炎患者病毒因素及宿主细胞免疫对干扰素治疗应答的影响[J].中华传染病杂志,2002,20(5):290-293. 被引量:10
  • 5焦健,王江滨.丙型肝炎病毒基因型及患者人类白细胞抗原对其抗病毒疗效的影响[J].中华肝脏病杂志,2003,11(10):620-622. 被引量:6
  • 6Enomoto M, Nishiguchi S, Tanaka M, et al. Dynamics of hepatitis C virus monitored by real-time quantitative polymerase chain reaction during first 2 weeks of IFN-beta treatment are predictive of long-term therapeutic response. J Interferon Cytokine Res, 2002, 22: 389-395.
  • 7Nakamuta M, Fukutomi T, Shimohashi N, et al. Kinetics of the hepatitis C virus during interferon therapy as a marker of therapeutic response. J Gastroenterol Hepatol, 2001, 16: 29-33.
  • 8Jessner W, Stauber R, Hackl F, et al. Early viral kinetics on treatment with pegylated interferon-alpha-2a in chronic hepatitis C virus genotype 1 infection. J Viral Hepat, 2003, 10: 37-42.

二级参考文献13

  • 1Kurosaki M, Enomoto N, Murakami T, et al. Analysis of genotypes and amino acid residues 2209 to 2248 of the NSSA region of hepatitis C virus in relation to the response to interferon-beta therapy.Hepatology, 1997, 25: 769-771.
  • 2Nelson DR, Marousis CG, Davis GL, et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol, 1997,158:1473-1481.
  • 3Lau JY, Mizokami M, Kolberg JA, et al. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis, 1995, 171: 281-289.
  • 4Lau JY, Davis GL, Brunson ME, et al. Hepatitis C virus infection in kindey transplant recipients. Hepatology, 1993,18:1027-1031.
  • 5Yoshioka K, Kakumu S, Wakita T, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon alpha therapy: relationship to genotypes of hepatitis C virus.Hepatology,1992,16:293-299.
  • 6Regino P, Gonzalez-Peralta RP, Qian K, et al. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. J Med Virol, 1996, 49: 242-247.
  • 7Enomoto N, Sakuma I, Asahina Y, et al. Comparison of full-length sequences of interferon-sesitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in NS5A region. J Clin Invest, 1995, 96: 224-230.
  • 8Lau JY, Bird GL, Naoumov NV, et al. Hepatic HLA antigens display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology. Dig Dis Sci, 1993, 38: 888-895.
  • 9Nelson DR, Marousis CG, Ohno T, et al. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C. Hepatology, 1998, 28: 225-230.
  • 10张复春,唐小平,蔡晓莉,吴婉芬.丙型肝炎病毒基因型与血清HCV RNA含量关系及与干扰素应答的研究[J].中华微生物学和免疫学杂志,1998,18(2):131-134. 被引量:12

共引文献14017

同被引文献47

引证文献7

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部